HomeAbout

TL;DR CNBC


Viking Therapeutics stock jumps more than 25% on promising weight loss pill data - TL;DR CNBC

Viking Therapeutics stock jumps more than 25% on promising weight loss pill data

Publishing timestamp: 2024-03-26 10:22:11


Summary

Viking Therapeutics shares jumped over 25% after announcing positive results for its experimental weight loss pill in a small study. The pill will enter the next stage of development later this year, adding to excitement around the company's prospects in the weight loss drug market. The once-a-day tablet is an oral version of their experimental weight loss injection, which also showed promising results in a previous trial.


Sentiment: POSITIVE

Tickers: NVOLLYNOVO.B-DKVKTX

Keywords: biotech and pharmaceuticalsbreaking newshealth care industrybiotechnologysciencebusinessviking therapeutics incpharmaceuticalseli lilly and cobusiness newsnovo nordisk a/s

Source: https://www.cnbc.com/2024/03/26/viking-therapeutics-weight-loss-pill-shows-positive-study-results.html


Developed by Leo Phan